Barely Significant
← all excerpts

Which ASDAS cut-off corresponds best to treatment intensification in patients with axial spondyloarthritis in daily practice? A prospective study from a clinical registry.

Rheumatol Int · 2025 · PMC12549769 · PMID 41128862

0
hedged sentences
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.